Article Information
History
- March 23, 2022.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Trine Strandgaard1,2,
- Sia Viborg Lindskrog1,2,
- Iver Nordentoft1,
- Emil Christensen1,2,
- Karin Birkenkamp-Demtröder1,2,
- Tine Ginnerup Andreasen1,2,
- Philippe Lamy1,
- Asbjørn Kjær1,2,
- Daniel Ranti3,
- Yuan-Sho Wang3,
- Christine Bieber3,
- Frederik Prip1,2,
- Julie Rasmussen1,2,
- Torben Steiniche2,4,
- Nicolai Birkbak1,2,
- John Sfakianos5,
- Amir Horowitz3,
- Jørgen Bjerggaard Jensen2,6 and
- Lars Dyrskjøt1,2,*
- 1Department of Molecular Medicine, Aarhus University Hospital, 8200 Aarhus N, Denmark
- 2Department of Clinical Medicine, Aarhus University, 8000 Aarhus, Denmark
- 3Department of Oncological Sciences, Precision Immunology Institute, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY
- 4Department of Pathology, Aarhus University Hospital, 8200 Aarhus N, Denmark
- 5Department of Urology, Icahn School of Medicine at Mount Sinai, New York, NY
- 6Department of Urology, Aarhus University Hospital, 8200 Aarhus N, Denmark
- ↵*Corresponding author:
Lars Dyrskjøt, Email: lars{at}clin.au.dk
Posted March 23, 2022.
Elevated T-cell exhaustion and urinary tumor DNA levels are associated with BCG failure in patients with non-muscle invasive bladder cancer
